EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of De Novo ZBTB18 Variant in a Patient With Global Developmental Delay, Seizures, and Juvenile Facies

Yan Wu iD, Bei Li iD, Liang Liu iD, Yan Wang iD, Dongjing Li iD

International Journal of Pediatrics · 2026-01 · 2026 (1)

DOI: 10.1155/ijpe/7226289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pediatrics, online erschienen am 23.05.2026. Verfasst von Yan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xi'an Children's Hospital, Xi'an, Shaanxi, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ZBTB18 encodes a C2H2‐type zinc finger protein that acts as a transcriptional repressor and is essential for neurodevelopment. Variants in ZBTB18 are associated with intellectual developmental disorder, autosomal dominant 22 (MRD22). Patients with MRD22 present with intellectual disability (ID), corpus callosum anomalies, hypotonia, microcephaly, growth problems, epilepsy, and variable facial dysmorphism.

Methods

Whole exome sequencing (WES) was performed to identify the molecular etiology. Sanger sequencing was used to validate the variant. Clinical assessments were conducted using brain magnetic resonance imaging (MRI) and electroencephalogram (EEG).

Results

Our patient presented with sleep‐associated focal motor seizures, characterized by right‐sided clonic movements with impaired consciousness, accompanied by atypical absence seizures. She also exhibited global developmental delay, unexplained ankle hypertonia, and unique juvenile facies (characterized by a lack of complex emotional expression, a fixed gaze, and an overall immature facial gestalt). Video EEG demonstrated hypsarrhythmia, whereas brain MRI revealed no structural abnormalities at the age of 2.5 years. The patient received antiepileptic therapy, and seizure control was successfully achieved following perampanel treatment. A de novo ZBTB18 variant (NM_205768.3: c.1474delA (p.Arg492Aspfs∗11)) was identified in our patient.

Conclusion

To conclude, we report a de novo ZBTB18 frameshift variant (NM_205768.3: c.1474delA (p.Arg492Aspfs∗11)) in a female patient presenting with global developmental delay, epilepsy, ankle hypertonia, and unique juvenile facies. Notably, seizures were ultimately controlled with perampanel, which may provide a therapeutic insight for drug‐resistant epilepsy in MRD22. Our study expands the phenotypic and genetic spectrum of ZBTB18 and provides novel insights into the clinical management of MRD22.

Schlagwörter

Stichwörter der Autor:innen

ZBTB18developmental delayintellectual developmental disorder autosomal dominant 22whole exome sequencing

Autor:innen und Institutionen

  • Department of Neurology, Xi'an Children's Hospital, Xi'an, Shaanxi, China.

ORCID-Profile: Yan Wu, Bei Li, Liang Liu, Yan Wang, Dongjing Li

Zitieren

APA

Wu, Y., Li, B., Liu, L., Wang, Y., & Li, D. (2026). Identification of De Novo ZBTB18 Variant in a Patient With Global Developmental Delay, Seizures, and Juvenile Facies. International Journal of Pediatrics, 2026(1). https://doi.org/10.1155/ijpe/7226289

Vancouver

Wu Y, Li B, Liu L, Wang Y, Li D. Identification of De Novo ZBTB18 Variant in a Patient With Global Developmental Delay, Seizures, and Juvenile Facies. International Journal of Pediatrics. 2026;2026(1). doi:10.1155/ijpe/7226289

BibTeX
@article{Wu2026,
  author = {Wu, Yan and Li, Bei and Liu, Liang and Wang, Yan and Li, Dongjing},
  title = {Identification of De Novo ZBTB18 Variant in a Patient With Global Developmental Delay, Seizures, and Juvenile Facies},
  journal = {International Journal of Pediatrics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijpe/7226289}
}
Kostenlos starten →